Acceptability of COVID-19 vaccination in Saudi Arabia: A cross-sectional study using a web-based survey.


Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
03 Oct 2021
Historique:
pubmed: 9 7 2021
medline: 16 9 2021
entrez: 8 7 2021
Statut: ppublish

Résumé

The success of COVID-19 vaccination depends on individual's vaccine acceptance. There has been misinformation on the media that doubts its effectiveness, safety, and long-term risk. Such controversy could affect the acceptance toward the uptake of the COVID-19 vaccine. The objective of this study was to assess the factors influencing the acceptance and hesitancy toward the COVID-19 vaccine in Saudi Arabia. A cross-sectional study was conducted. An online survey was conducted with four parameters: Demographics, medical history, knowledge and information sources about COVID-19 and vaccine, and hesitancy/acceptance of vaccinations. Bivariate analysis between several survey items and the acceptance of COVID-19 vaccine was conducted using Chi-square test. Logistic regression was used to assess to what degree each variable affects the acceptance and the hesitancy toward the COVID-19 vaccine. Approximately 64% show a desire to accept the vaccine while 18.3% were extremely hesitant to take the vaccine. Non-demographic factors that were associated with the acceptance toward the COVID-19 vaccine were the source of health information about COVID-19 (OR:1.63; 95% CI:1.07-2.47), perception toward whether the vaccine is effective on other variants of the virus (OR:7.24; 95% CI:4.58-11.45), previous uptake of the influenza vaccine (OR:1.62; 95% CI:1.07-2.47), and potential mandatory of vaccination in order to travel internationally (OR:16.52; 95% CI:10.23-26.68). This study provides an insight into factors - other than the sociodemographic - influencing the acceptance of the COVID-19 vaccine in Saudi Arabia. The government should address the COVID-19-related misinformation and rumors to increase acceptance of COVID-19 vaccination.

Identifiants

pubmed: 34236290
doi: 10.1080/21645515.2021.1936869
pmc: PMC8437496
doi:

Substances chimiques

COVID-19 Vaccines 0
Influenza Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3338-3347

Références

BMJ. 2020 Dec 11;371:m4799
pubmed: 33310748
Pharm Pract (Granada). 2021 Jan-Mar;19(1):2317
pubmed: 33828623
Vaccines (Basel). 2020 Aug 27;8(3):
pubmed: 32867224
J Med Ethics. 2021 Oct;47(10):709-711
pubmed: 33504627
J Multidiscip Healthc. 2020 Nov 20;13:1657-1663
pubmed: 33262600
JAMA Netw Open. 2020 Oct 1;3(10):e2025594
pubmed: 33079199
J Hosp Infect. 2021 Feb;108:168-173
pubmed: 33259883
Nurs Health Sci. 2010 Sep 1;12(3):369-74
pubmed: 20727089
Vaccines (Basel). 2021 Feb 14;9(2):
pubmed: 33672938
Vaccine. 2011 Sep 2;29(38):6472-84
pubmed: 21756960
Nat Hum Behav. 2021 Mar;5(3):337-348
pubmed: 33547453
Virus Res. 2020 Oct 15;288:198114
pubmed: 32800805
Crit Rev Diagn Imaging. 1989;29(3):307-35
pubmed: 2667567
Front Public Health. 2020 Jul 14;8:381
pubmed: 32760691
BMJ Glob Health. 2020 Oct;5(10):
pubmed: 33097547
J Infect Dis. 2020 Aug 4;222(5):715-718
pubmed: 32582943
BMJ. 2021 Jan 18;372:n158
pubmed: 33462092
Vaccines (Basel). 2021 Mar 03;9(3):
pubmed: 33802285
Vaccines (Basel). 2021 Feb 16;9(2):
pubmed: 33669441
PLoS One. 2021 Apr 16;16(4):e0250123
pubmed: 33861765
BMC Public Health. 2021 Jul 21;21(1):1438
pubmed: 34289817
Am J Trop Med Hyg. 2020 Aug;103(2):603-604
pubmed: 32588810
J Microbiol Immunol Infect. 2020 Jun;53(3):377-380
pubmed: 32205090
J Travel Med. 2020 Dec 23;27(8):
pubmed: 32749458
Am J Epidemiol. 1977 May;105(5):488-95
pubmed: 871121
Vaccines (Basel). 2021 Apr 01;9(4):
pubmed: 33915890
J Med Virol. 2021 Jul;93(7):4280-4291
pubmed: 33644891
BMJ. 2020 Dec 16;371:m4857
pubmed: 33328153
Vaccine. 2020 Nov 17;38(49):7789-7798
pubmed: 33109389

Auteurs

Saeed Mastour Alshahrani (SM)

College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia.

Salem Dehom (S)

Department of Graduate Studies, Loma Linda University - School of Nursing, Loma Linda, CA, USA.

Diaa Almutairi (D)

Department of Oral Health, Prince Sultan Military College of Health Sciences, Dhahran, Saudi Arabia.
School of Medicine and Dentistry, Queen Mary University of London, London UK.

Badr Saud Alnasser (BS)

Department of Health Management, College of Public Health and Health Informatics, University of Ha'il, Hail, Saudi Arabia.

Bandar Alsaif (B)

Department of Public Health, University of Ha'il, Hail, Saudi Arabia.

Ahmed A Alabdrabalnabi (AA)

Department of Public Health, College of Health Sciences, Saudi Electronic University, Dammam, Saudi Arabia.

Abdullah Bin Rahmah (A)

College of Dentistry, King Saud University, Riyadh, Saudi Arabia.
Faculty of Biology, Medicine and Health, the University of Manchester, UK.

Mastour Safar Alshahrani (MS)

Dental Department, Ministry of Health, Khamis Mushayt, Saudi Arabia.

Ashraf El-Metwally (A)

College of Public Health and Health Informatics, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.

Badr F Al-Khateeb (BF)

College of Public Health and Health Informatics, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Department of Family Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia.

Fatmah Othman (F)

College of Applied Medical Sciences, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.

Mohammad Mahtab Alam (M)

College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH